Mastek Ltd. reported its Q3FY25 outcomes as we speak, revealing a combined efficiency. The corporate recorded income of ₹869.5 crore for the quarter ending December 31, 2024, marking a year-on-year (YoY) improve of 10.9 per cent. Nevertheless, sequential income progress was marginal at 0.2 per cent. Internet revenue stood at ₹94.7 crore, rising 21.8 per cent YoY however dropping considerably by 26.4 per cent from Q2FY25.
Working EBITDA for the quarter was ₹140.7 crore, translating to a margin of 16.2 per cent, barely decrease than 16.5 per cent in Q2FY25. The decline in profitability displays the affect of wage hikes and seasonal furloughs. Mastek’s twelve-month order backlog grew by 3.4 per cent YoY to ₹2,138.7 crore.
For the 9 months ended December 31, 2024, Mastek posted income of ₹2,549.8 crore, up 12.1 per cent YoY. Internet revenue for this era was ₹294.9 crore, registering a powerful 36.2 per cent YoY progress. The corporate attributed this progress to deeper account mining and improved income per consumer. Regardless of these positive aspects, the corporate’s quarterly efficiency indicated challenges in sustaining momentum.
The healthcare vertical stood out, recording 19.6 per cent quarter-on-quarter (QoQ) progress, whereas different sectors confirmed stability. Mastek additionally declared an interim dividend of ₹7 per share, underscoring its dedication to shareholder returns.
CEO Umang Nahata emphasised the corporate’s deal with integrating AI into its companies to reinforce supply effectivity and consumer options. He highlighted plans to increase AI-based platforms and options over the subsequent yr.
Trying forward, CFO Arun Agarwal reiterated Mastek’s goal to keep up disciplined execution and prudent useful resource allocation amid geopolitical uncertainties and market challenges.
The shares of Mastek Ltd closed at ₹2,760, up by ₹27.10 or 0.99 per cent on the NSE as we speak
